Rebekah Gensure
Retina Specialist · Salt Lake City, UTNPI 1225490444
Payments from drug & device makers
What this record shows
Apellis Pharmaceuticals, Inc. accounts for 68.8% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $3,542, more than ten times the $247 reported in 2019.
Across 43 payments — averaging $106.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Apellis Pharmaceuticals, Inc.$3K
- Genentech USA, Inc.$410
- Alcon$240
- Regeneron Healthcare Solutions, Inc.$198
- Biogen$138
- Bausch & Lomb Americas Inc.$96
- plus $350 from 7 others
What the payments were for
- Consulting fees$2,65558%
- Food & beverage$1,93542%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | 9 | $3,158 |
| Genentech USA, Inc. | 9 | $410 |
| Alcon | 6 | $240 |
| Regeneron Healthcare Solutions, Inc. | 4 | $198 |
| Biogen | 2 | $138 |
| Bausch & Lomb Americas Inc. | 2 | $96 |
| Regeneron | 1 | $89 |
| Lumibird Medical Inc. | 1 | $60 |
| AbbVie(2 entities) | 2 | $48 |
| Astellas Pharma US Inc | 3 | $47 |
| Neurotech Pharmaceuticals, Inc. | 1 | $44 |
| Dompe US, Inc. | 2 | $43 |
| Harrow Eye, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,589 in reported general payments places this provider in the 75th percentile of 20 retina specialist providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 62 | $2,059 |
| Ofloxacin | 45 | $516 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 19 | $265 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Salt Lake City
- Robert KwunSalt Lake City$334K
- Mitchell GoffSalt Lake City$165K
- James HowardSalt Lake City$14K
- David FaberSalt Lake City$10K
- Kirk WinwardSalt Lake City$3K
- Eric BrintonSalt Lake City$3K
- Gregory BrintonSalt Lake City$1K
- Mano SwartzSalt Lake City$28
- Andrew DavisWest Jordan$4K
- Joshua CarlsonSt George$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.